CRH Medical has 63 per cent upside, Beacon Securities says

Nov 05 21:11 2018 Print This Article

Following the company’s third quarter results, Beacon Securities analyst Doug Cooper is still bullish on CRH Medical (CRH Medical Stock Quote, Chart: TSX:CRH). On October 31, CRH reported its Q3, 2018 results. The company posted EBITDA of $8.5-million on revenue of $28.7-million, a topline that was up 29 per cent over the same period last […]

The post CRH Medical has 63 per cent upside, Beacon Securities says appeared first on Cantech Letter.

Read More

About Article Author

Cantech Letter

Founded in 2008 by Nick Waddell, Cantech Letter is an online magazine focusing on Canadian technology. The site has grown into one of the most popular and respected financial sites in Canada, and was described by Canadian Business Magazine as “one of Canada’s premier technology newsletters”. Waddell, who is Senior Editor, is routinely called on by the mainstream media for perspective on Canadian technology, and has been featured on BNN, CTV News Channel, and the CBC program “The Lang and O’Leary Exchange” in addition to mainstream print media such as The Guardian, The International Business Times, The Globe and Mail, Macleans, The Waterloo Record , Canadian Business, Slate, and Business Insider. You can email Nick at nick@cantechletter.com Cantech Letter is focused on those companies listed on the TSX and TSXV Technology, Cleantech and Life Sciences Sectors. Each year we present the Cantech Letter Awards, which honor Canada’s Top Technology Stock and Top Technology Stock Executive.

Related Items

MedX Health has tons of upside, says Beacon Securities

Beacon Securities analyst Doug Cooper thinks the market has so far ignored a series of recent game-changing announcements by medical technology company MedX Health (MedX Health Stock Quote, Chart, News TSXV:MDX). That scenario, said Cooper in a June 16 update to clients, makes for a prime investmen ...

Profound Medical is insulated from COVID-19, says Raymond James

Looking for bright spots within the ongoing market deluge? Raymond James analyst Rahul Sarugaser says Profound Medical (Profound Medical Stock Quote, Chart, News TSX:PRN) should be top of mind, as the company appears to be well-insulated with respect to the COVID-19 pandemic. In an update to client ...

CRH Medical has price target cut at Beacon Securities

CRH Medical Corporation (CRH Medical Corporation Stock Quote, Chart, News TSX:CRH) hung onto its “Buy” rating from Beacon Securities analyst Doug Cooper after disappointing fourth quarter results. The analyst reviewed the Q4 in an update to clients on Thursday and reduced his target by half. Va ...

There’s still upside to Aurinia Pharma, says Mackie Research

All eyes are on a 2021 launch of voclosporin, lead candidate from drug developer Aurinia Pharmaceuticals (Aurinia Pharma Stock Quote, Chart, News NASDAQ:AUPH), but the stock received a target price trim from analyst André Uddin of Mackie Research on Friday, going from $24.00 to $22.00 per share. V ...

Oncolytics Biotech is “dramatically undervalued”, says Echelon Wealth

Alberta-based biologics developer Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart, News TSX:ONC) has a clear roster of clinical milestones ahead for its flagship virus formulation, according to Echelon Wealth Partners analyst Doug Loe, who reviewed the company’s quarterly results and ge ...

Profound Medical is a Raymond James Best Pick for 2020

In his words, Raymond James analyst Rahul Sarugaser is expecting “massive recurring revenue” coming from Profound Medical (Profound Medical Stock Quote, Chart, News TSX:PRN) once the commercialization of its TULSA-PRO medical device really picks up steam. In a review of the company’s latest q ...

Theratechnologies new CEO gets thumbs up at Mackie Research

After a passing of the torch to a new CEO for Theratechnologies (Theratechnologies Stock Quote, Chart, News TSX:TH), analyst André Uddin of Mackie Research is sticking with his assessment of the company, saying in an update to clients on Monday that at these prices the stock is a bargain. Montreal ...

Q4 2019 Share Price Performance

Q4 2019 Share Price Performance Healthcare Stocks Surge  In this blog post, the Bloom Burton equity research team summarizes the performance of the Canadian healthcare sector during 4Q-2019, and provides commentary on select stock movements and overall market trends.  Inclusion Criteria  Our ana ...

Centric Health is one of my top picks: Stephen Takacsy

Centric Health (Centric Health Stock Quote, Chart, News TSX:CHH) is one beaten up stock you might want to look at. The healthcare company had been mired in debt for a number of years but has recently made moves to right the ship, says Stephen Takacsy of Lester Asset Management, who calls Centric a ...

Three reasons to buy Theratechnologies from Mackie Research

Mackie Research analyst André Uddin is staying bullish on specialty pharma company Theratechnologies (Theratechnologies Stock Quote, Chart, News TSX:TH) after its latest quarterly results. The analyst reviewed Theratechnologies fourth quarter in a report to clients on Tuesday and reiterated his ...